Literature DB >> 16698396

Surgery for ovarian cancer: how to improve survival.

Robert E Bristow1, Jonathan S Berek.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16698396     DOI： 10.1016/S0140-6736(06)68671-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli-Leydig cell tumour.

Authors:  Zaina S Inam; Abdul Hussain Azizi; Soemiwati W Holland
Journal:  BMJ Case Rep       Date:  2018-03-01

2.  Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer.

Authors:  Fusa Ogata; Tadanobu Nagaya; Yasuhiro Maruoka; Joshua Akhigbe; Adam Meares; Melissa Y Lucero; Andrius Satraitis; Daiki Fujimura; Ryuhei Okada; Fuyuki Inagaki; Peter L Choyke; Marcin Ptaszek; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2018-12-14       Impact factor: 4.774

3.  Peritoneal carcinosis of ovarian origin.

Authors:  Anna Fagotti; Valerio Gallotta; Federico Romano; Francesco Fanfani; Cristiano Rossitto; Angelica Naldini; Massimo Vigliotta; Giovanni Scambia
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

Review 4.  Centralisation of services for gynaecological cancer.

Authors:  Yin Ling Woo; Maria Kyrgiou; Andrew Bryant; Thomas Everett; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

5.  A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer.

Authors:  Kenneth H Kim; Igor Dmitriev; Janis P O'Malley; Minghui Wang; Souheil Saddekni; Zhiying You; Meredith A Preuss; Raymond D Harris; Rosemarie Aurigemma; Gene P Siegal; Kurt R Zinn; David T Curiel; Ronald D Alvarez
Journal:  Clin Cancer Res       Date:  2012-04-17       Impact factor: 12.531

6.  E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.

Authors:  Narasimhan Kothandaraman; Vladimir B Bajic; Pang N K Brendan; Chan Y Huak; Peh B Keow; Khalil Razvi; Manuel Salto-Tellez; Mahesh Choolani
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

7.  A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Authors:  Kenneth H Kim; Igor P Dmitriev; Souheil Saddekni; Elena A Kashentseva; Raymond D Harris; Rosemarie Aurigemma; Sejong Bae; Karan P Singh; Gene P Siegal; David T Curiel; Ronald D Alvarez
Journal:  Gynecol Oncol       Date:  2013-06-10       Impact factor: 5.482

8.  Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.

Authors:  Quirijn R J G Tummers; Charlotte E S Hoogstins; Katja N Gaarenstroom; Cor D de Kroon; Mariette I E van Poelgeest; Jaap Vuyk; Tjalling Bosse; Vincent T H B M Smit; Cornelis J H van de Velde; Adam F Cohen; Philip S Low; Jacobus Burggraaf; Alexander L Vahrmeijer
Journal:  Oncotarget       Date:  2016-05-31

9.  Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy.

Authors:  Anthony Park; Chindu Govindaraj; Sue D Xiang; Julene Halo; Michael Quinn; Karen Scalzo-Inguanti; Magdalena Plebanski
Journal:  Cancers (Basel)       Date:  2012-06-18       Impact factor: 6.639

Review 10.  Cytoreductive surgery in ovarian cancer.

Authors:  Christophe Pomel; Arjun Jeyarajah; David Oram; John Shepherd; David Milliken; Jacques Dauplat; Karina Reynolds
Journal:  Cancer Imaging       Date:  2007-12-17       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.